RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+6.66%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$328M
AUM Growth
+$328M
(+31%)
Cap. Flow
+$74.7M
Cap. Flow
% of AUM
22.76%
Top 10 Holdings %
Top 10 Hldgs %
36.15%
Holding
103
New
20
Increased
33
Reduced
37
Closed
13
Top Buys
| 1 |
Pfizer
PFE
|
$11.3M |
| 2 |
Gilead Sciences
GILD
|
$9.9M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$9.39M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$6.73M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$5.64M |
Top Sells
| 1 |
Innoviva
INVA
|
$4.71M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$3.73M |
| 3 |
Intuitive Surgical
ISRG
|
$3.07M |
| 4 |
Zimmer Biomet
ZBH
|
$2.8M |
| 5 |
AET
Aetna Inc
AET
|
$2.74M |
Sector Composition
| 1 | Healthcare | 80.94% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Amgen
AMGN
$153B
| $3.95M | 1.19% |
+46,135
| New | +$3.95M |
|
27
Boston Scientific
BSX
$159B
| $3.85M | 1.16% |
284,978
+9,978
| +4% | +$135K |
|
28
HCA Healthcare
HCA
$95.4B
| $3.69M | 1.11% |
70,262
+15,262
| +28% | +$801K |
|
|
CTRX
29
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $3.62M | 1.09% |
+80,880
| New | +$3.62M |
|
30
Edwards Lifesciences
EW
$47.7B
| $3.43M | 1.03% |
+46,187
| New | +$3.43M |
|
|
AGN
31
DELISTED
ALLERGAN INC
AGN
| $3.42M | 1.03% |
27,516
+2,516
| +10% | +$312K |
|
|
NUVA
32
DELISTED
NuVasive, Inc.
NUVA
| $3.4M | 1.02% |
+88,442
| New | +$3.4M |
|
33
DexCom
DXCM
$30.9B
| $3.26M | 0.98% |
78,788
+1,788
| +2% | +$74K |
|
|
COV
34
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $3.26M | 0.98% |
44,221
-779
| -2% | -$57.4K |
|
35
Bristol-Myers Squibb
BMY
$96.7B
| $3.18M | 0.95% |
86,815
+14,815
| +21% | +$542K |
|
|
AEGR
36
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $3.15M | 0.95% |
68,395
-6,605
| -9% | -$305K |
|
37
Eli Lilly
LLY
$661B
| $3.15M | 0.94% |
53,458
+18,458
| +53% | +$1.09M |
|
38
Centene
CNC
$14.8B
| $2.94M | 0.88% |
47,169
+12,169
| +35% | +$757K |
|
39
UnitedHealth
UNH
$279B
| $2.85M | 0.86% |
62,979
+18,979
| +43% | +$860K |
|
|
ESRX
40
DELISTED
Express Scripts Holding Company
ESRX
| $2.84M | 0.85% |
37,834
-27,166
| -42% | -$2.04M |
|
41
Insulet
PODD
$24.2B
| $2.8M | 0.84% |
58,961
-16,039
| -21% | -$761K |
|
42
McKesson
MCK
$85.9B
| $2.77M | 0.83% |
26,620
+13,620
| +105% | +$1.42M |
|
43
Community Health Systems
CYH
$392M
| $2.69M | 0.81% |
68,788
+23,788
| +53% | +$932K |
|
44
Ligand Pharmaceuticals
LGND
$3.25B
| $2.66M | 0.8% |
39,567
+1,567
| +4% | +$105K |
|
|
PRXL
45
DELISTED
Parexel International Corp
PRXL
| $2.66M | 0.8% |
49,135
-8,865
| -15% | -$480K |
|
|
ELGX
46
DELISTED
Endologix Inc
ELGX
| $2.6M | 0.78% |
201,843
+120,816
| +149% | +$1.56M |
|
|
THOR
47
DELISTED
THORATEC CORPORATION
THOR
| $2.46M | 0.74% |
68,788
-6,212
| -8% | -$222K |
|
48
Medtronic
MDT
$118B
| $2.43M | 0.73% |
39,429
-35,571
| -47% | -$2.19M |
|
|
OCR
49
DELISTED
OMNICARE INC
OCR
| $2.35M | 0.7% |
39,308
+2,308
| +6% | +$138K |
|
|
ABMD
50
DELISTED
Abiomed Inc
ABMD
| $2.34M | 0.7% |
89,916
+24,916
| +38% | +$649K |
|